Roche has posted a mixed set of data from two clinical trials of its anti-IL-33/ST2 antibody astegolimab in chronic obstructive pulmonary disease (COPD), casting a shadow over the programme. On the ...

AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...

When you feel like you can't breathe deeply enough, can't get enough air, or are working too hard to breathe, you have shortness of breath. Doctors sometimes call it dyspnea. Shortness of breath can ...